|
|
|
|
|
by ThrustVectoring
1273 days ago
|
|
Pure majoritarianism isn't necessarily best either, it just always takes the majority's side in disputes where a strongly-held minority opinion comes in conflict with a weakly-held majority one. Like, it's obvious that you should take the side of the majority when it's "we'd rather not be slightly inconvenienced by paying for rent-seekers" regardless of how intensely the minority of rent-seekers want to rent-seek, but it's much less obvious that we should have zero handouts to narrow interests when it's "please spend $10000 per life saved via rare-disease research and treatment, I don't care how little the general public is aware of and cares about it and would generally prefer lower taxes" |
|
In reality, this turns into we should have billion dollar handouts to narrow interests because rather than use taxpayer funds to R&D cures into the public domain using the existing world class university system, the narrow interests would prefer being able to benefit from patented medicines:
https://www.wsj.com/articles/drug-prices-reach-new-highin-th...
> Since August, U.S. or European health regulators have approved four new products intended as one-time treatments for rare genetic diseases that carry list prices of at least $2 million a patient, including two from Bluebird Bio Inc.